GLOBAL LEADER IN PELLETIZED CONTROLLED RELEASE FORMULATIONS AND MANUFACTURING TOUTS THEIR CONCEPTS AND TECHNOLOGY AS THE "BENCHMARK FOR THE FUTURE" WITHIN THE EXPLODING HIGH-END DIETARY SUPPLEMENT INDUSTRY. COMPANY ESTABLISHES BASE OF OPERATIONS IN U.S.

Pompano Beach, Florida—February 2003 Manufacturers and formulators in the $30 Billion+ food supplement industry continually seek-out more effective methods to deliver specialized nutrients efficiently, increase user compliance and lessen side effects. The overwhelming majority of products currently on the market today utilize immediate release dosage forms in either solid, powder or liquid sparking criticism concerning the questionable absorption rates of vitamins and/or nutrients contained in products using these forms. Addressing the concerns of the scientific community while concurrently developing its presence with small to mid-size North American supplement manufacturers, Osmopharm USA the North American arm of Osmopharm S.A., plans to continue to apply its novel delivery methods through research, development and contract manufacturing of its controlled release products here in the United States. The near-term goal—according to Isaac Gilinski, President of Osmopharm USA, LLC—is to demonstrate how the application of controlled release delivery systems can "meet the needs of an ever more knowledgeable consumer while providing a better quality product and enhancing profitability for manufacturers and distributors."

With over 16 years of experience, Osmopharm S.A. manufactures modified release products,
presently producing over 150 Million doses per month from facilities in Switzerland and South America. "So much of what we are seeing in the food supplement industry points us to controlled release forms as a substantially more effective and a sophisticated alternative to the traditional," commented Gilinski.

Osmopharm's products have been well-received by both the pharmaceutical and supplement industries, however, for the food supplement industry, it is regarded as a unique and more effective way to enhance existing formulations or for formulators to design products around with very marketable advantages: 1) active principles to become bio-available via their release through a coating—thus providing modulated absorption in the body. This translates into a more rational in-vivo performance with advantages being lower gastric irritation due to homogeneous distribution in the GI tract; 2) decreased side effects due to avoidance of peaks and valleys in blood levels; 3) and better user compliance due to reducing the number of doses. According to dietary supplement industry expert Dr. George Weil, there is a fundamental benefit for firms seeking to utilize Osmopharm's technology. He says "Science is the future of the dietary supplement industry and Osmopharm is the future. Time-released capsules are the most powerful tool we are able to offer to consumers and certainly the most intelligent way of taking food supplements to assure total benefit."

Osmopharm invites inquiries from wholesalers, marketers and manufacturers concerning its product line and potential for custom applications. Please contact: Isaac Gilinski, President, OSMOPHARM USA, LLC, 1893 SW Third St, Pompano Beach, FL 33069, Phone: 800-440-6470 (toll free) or 954-979-6440; e-mail: info@gilinskigroup.com.




This article courtesy of http://www.yourcalciumguide.info/.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Submit Your Article